{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:50:19Z","timestamp":1776174619284,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901277"],"award-info":[{"award-number":["81901277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801190"],"award-info":[{"award-number":["81801190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701155"],"award-info":[{"award-number":["81701155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108014"],"award-info":[{"award-number":["81820108014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Postdoctoral Foundation of Heilongjiang Province","award":["LBH-Z17138"],"award-info":[{"award-number":["LBH-Z17138"]}]},{"name":"The Postdoctoral Foundation of Heilongjiang Province","award":["LBH-Z18204"],"award-info":[{"award-number":["LBH-Z18204"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation Grant","doi-asserted-by":"crossref","award":["2018M640307"],"award-info":[{"award-number":["2018M640307"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFE0114400"],"award-info":[{"award-number":["2018YFE0114400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myasthenia gravis (MG) is an autoimmune disease and the most common type of neuromuscular disease. Genes and miRNAs associated with MG have been widely studied; however, the molecular mechanisms of transcription factors (TFs) and the relationship among them remain unclear. A TF\u2013miRNA\u2013gene network (TMGN) of MG was constructed by extracting six regulatory pairs (TF\u2013miRNA, miRNA\u2013gene, TF\u2013gene, miRNA\u2013TF, gene\u2013gene and miRNA\u2013miRNA). Then, 3\/4\/5-node regulatory motifs were detected in the TMGN. Then, the motifs with the highest Z-score, occurring as 3\/4\/5-node composite feed-forward loops (FFLs), were selected as statistically significant motifs. By merging these motifs together, we constructed a 3\/4\/5-node composite FFL motif-specific subnetwork (CFMSN). Then, pathway and GO enrichment analyses were performed to further elucidate the mechanism of MG. In addition, the genes, TFs and miRNAs in the CFMSN were also utilized to identify potential drugs. Five related genes, 3 TFs and 13 miRNAs, were extracted from the CFMSN. As the most important TF in the CFMSN, MYC was inferred to play a critical role in MG. Pathway enrichment analysis showed that the genes and miRNAs in the CFMSN were mainly enriched in pathways related to cancer and infections. Furthermore, 21 drugs were identified through the CFMSN, of which estradiol, estramustine, raloxifene and tamoxifen have the potential to be novel drugs to treat MG. The present study provides MG-related TFs by constructing the CFMSN for further experimental studies and provides a novel perspective for new biomarkers and potential drugs for MG.<\/jats:p>","DOI":"10.1038\/s41598-021-81962-6","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:12:46Z","timestamp":1611832366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Construction of a TF\u2013miRNA\u2013gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis"],"prefix":"10.1038","volume":"11","author":[{"given":"Chunrui","family":"Bo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuze","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aigul","family":"Saitgareeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaysina","family":"Lyaysan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangwei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"81962_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus, N. E. Myasthenia gravis. N. Engl. J. Med. 375, 2570\u20132581 (2016).","journal-title":"N. Engl. J. Med."},{"key":"81962_CR2","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1151651","volume":"319","author":"O Hobert","year":"2008","unstructured":"Hobert, O. Gene regulation by transcription factors and microRNAs. Science 319, 1785\u20131786 (2008).","journal-title":"Science"},{"key":"81962_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clim.2015.12.009","volume":"164","author":"XF Liu","year":"2016","unstructured":"Liu, X. F. et al. MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10. Clin. Immunol. 164, 106\u2013113 (2016).","journal-title":"Clin. Immunol."},{"key":"81962_CR4","doi-asserted-by":"publisher","first-page":"e0205464","DOI":"10.1371\/journal.pone.0205464","volume":"13","author":"M Sengupta","year":"2018","unstructured":"Sengupta, M. & Wang, B. D. MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis. PLoS ONE 13, e0205464 (2018).","journal-title":"PLoS ONE"},{"key":"81962_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08916934.2018.1454913","volume":"51","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Altered expression of transcription factors IRF4 and IRF8 in peripheral blood B cells is associated with clinical severity and circulating plasma cells frequency in patients with myasthenia gravis. Autoimmunity 51, 126\u2013134 (2018).","journal-title":"Autoimmunity"},{"key":"81962_CR6","doi-asserted-by":"publisher","first-page":"e12676","DOI":"10.1111\/sji.12676","volume":"88","author":"QR Li","year":"2018","unstructured":"Li, Q. R. et al. The overexpression of Fra1 disorders the inflammatory cytokine secretion by mTEC of myasthenia gravis thymus. Scand. J. Immunol. 88, e12676 (2018).","journal-title":"Scand. J. Immunol."},{"key":"81962_CR7","doi-asserted-by":"publisher","first-page":"11980","DOI":"10.1073\/pnas.2133841100","volume":"100","author":"S Mangan","year":"2003","unstructured":"Mangan, S. & Alon, U. Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. USA 100, 11980\u201311985 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81962_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molcel.2007.05.018","volume":"26","author":"J Tsang","year":"2007","unstructured":"Tsang, J., Zhu, J. & van Oudenaarden, A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell. 26, 753\u2013767 (2007).","journal-title":"Mol. Cell."},{"key":"81962_CR9","doi-asserted-by":"publisher","first-page":"e1002488","DOI":"10.1371\/journal.pcbi.1002488","volume":"8","author":"J Sun","year":"2012","unstructured":"Sun, J., Gong, X., Purow, B. & Zhao, Z. Uncovering MicroRNA and transcription factor mediated regulatory networks in glioblastoma. PLoS Comput. Biol. 8, e1002488 (2012).","journal-title":"PLoS Comput. Biol."},{"key":"81962_CR10","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1007\/s12035-018-0963-6","volume":"55","author":"SS Nampoothiri","year":"2018","unstructured":"Nampoothiri, S. S., Fayaz, S. M. & Rajanikant, G. K. A novel five-node feed-forward loop unravels miRNA-gene-TF regulatory relationships in ischemic stroke. Mol. Neurobiol. 55, 8251\u20138262 (2018).","journal-title":"Mol. Neurobiol."},{"key":"81962_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbamcr.2016.11.007","volume":"1864","author":"T Engel","year":"2017","unstructured":"Engel, T. et al. A calcium-sensitive feed-forward loop regulating the expression of the ATP-gated purinergic P2X7 receptor via specificity protein 1 and microRNA-22. Biochim. Biophys. Acta Mol. Cell Res. 1864, 255\u2013266 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"81962_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/jcmm.13928","volume":"23","author":"H Shi","year":"2019","unstructured":"Shi, H. et al. Systematic identification and analysis of dysregulated miRNA and transcription factor feed-forward loops in hypertrophic cardiomyopathy. J. Cell Mol. Med. 23, 306\u2013316 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"81962_CR13","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1073\/pnas.200327197","volume":"97","author":"LA Amaral","year":"2000","unstructured":"Amaral, L. A., Scala, A., Barthelemy, M. & Stanley, H. E. Classes of small-world networks. Proc. Natl. Acad. Sci. USA 97, 11149\u201311152 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81962_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.tig.2004.04.008","volume":"20","author":"H Yu","year":"2004","unstructured":"Yu, H., Greenbaum, D., Xin Lu, H., Zhu, X. & Gerstein, M. Genomic analysis of essentiality within protein networks. Trends Genet. 20, 227\u2013231 (2004).","journal-title":"Trends Genet."},{"key":"81962_CR15","doi-asserted-by":"publisher","first-page":"e104827","DOI":"10.1371\/journal.pone.0104827","volume":"9","author":"L Yang","year":"2014","unstructured":"Yang, L. et al. Identifying a polymorphic \u201cswitch\u201d that influences miRNAs\u2019 regulation of a myasthenia gravis risk pathway. PLoS ONE 9, e104827 (2014).","journal-title":"PLoS ONE"},{"key":"81962_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3892\/ijmm.2017.2853","volume":"39","author":"Y Cao","year":"2017","unstructured":"Cao, Y. et al. Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis. Int. J. Mol. Med. 39, 268\u2013278 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"81962_CR17","first-page":"2350","volume":"19","author":"C Bo","year":"2019","unstructured":"Bo, C. et al. Global pathway view analysis of microRNA clusters in myasthenia gravis. Mol. Med. Rep. 19, 2350\u20132360 (2019).","journal-title":"Mol. Med. Rep."},{"key":"81962_CR18","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/bioinformatics\/btl038","volume":"22","author":"S Wernicke","year":"2006","unstructured":"Wernicke, S. & Rasche, F. FANMOD: a tool for fast network motif detection. Bioinformatics 22, 1152\u20131153 (2006).","journal-title":"Bioinformatics"},{"key":"81962_CR19","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/gb-2013-14-8-r85","volume":"14","author":"M Megraw","year":"2013","unstructured":"Megraw, M., Mukherjee, S. & Ohler, U. Sustained-input switches for transcription factors and microRNAs are central building blocks of eukaryotic gene circuits. Genome Biol. 14, R85 (2013).","journal-title":"Genome Biol."},{"key":"81962_CR20","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1093\/bioinformatics\/btv159","volume":"31","author":"C Liang","year":"2015","unstructured":"Liang, C., Li, Y., Luo, J. & Zhang, Z. A novel motif-discovery algorithm to identify co-regulatory motifs in large transcription factor and microRNA co-regulatory networks in human. Bioinformatics 31, 2348\u20132355 (2015).","journal-title":"Bioinformatics"},{"key":"81962_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature11245","volume":"489","author":"MB Gerstein","year":"2012","unstructured":"Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91\u2013100 (2012).","journal-title":"Nature"},{"key":"81962_CR22","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1073\/pnas.0801372105","volume":"105","author":"RJ Morgan","year":"2008","unstructured":"Morgan, R. J. & Soltesz, I. Nonrandom connectivity of the epileptic dentate gyrus predicts a major role for neuronal hubs in seizures. Proc. Natl. Acad. Sci. USA 105, 6179\u20136184 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81962_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0165-5728(01)00252-1","volume":"115","author":"T Nagata","year":"2001","unstructured":"Nagata, T. et al. Decreased expression of c-myc family genes in thymuses from myasthenia gravis patients. J. Neuroimmunol. 115, 199\u2013202 (2001).","journal-title":"J. Neuroimmunol."},{"key":"81962_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12920-015-0087-z","volume":"8","author":"Z Luo","year":"2015","unstructured":"Luo, Z. et al. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes. BMC Med. Genom. 8, 13 (2015).","journal-title":"BMC Med. Genom."},{"key":"81962_CR25","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1158\/0008-5472.CAN-10-3295","volume":"71","author":"PS Mongroo","year":"2011","unstructured":"Mongroo, P. S. et al. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. Cancer Res. 71, 2172\u20132182 (2011).","journal-title":"Cancer Res."},{"key":"81962_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12185-009-0256-y","volume":"89","author":"K Shamsasenjan","year":"2009","unstructured":"Shamsasenjan, K. et al. IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells. Int. J. Hematol. 89, 310\u2013318 (2009).","journal-title":"Int. J. Hematol."},{"key":"81962_CR27","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s11481-013-9498-9","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang, J. et al. Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response. J. Neuroimmune Pharmacol. 8, 1287\u20131302 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"81962_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10753-017-0514-8","volume":"40","author":"J Cheng","year":"2017","unstructured":"Cheng, J. et al. miRNA-451a targets IFN regulatory factor 8 for the progression of systemic lupus erythematosus. Inflammation 40, 676\u2013687 (2017).","journal-title":"Inflammation"},{"key":"81962_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606\u2013619 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"81962_CR30","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.1073\/pnas.0710441105","volume":"105","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105, 9331\u20139336 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81962_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2018.09.012","volume":"325","author":"K Iwasa","year":"2018","unstructured":"Iwasa, K., Yoshikawa, H., Furukawa, Y. & Yamada, M. Programmed cell death ligand 1 expression is upregulated in the skeletal muscle of patients with myasthenia gravis. J. Neuroimmunol. 325, 74\u201378 (2018).","journal-title":"J. Neuroimmunol."},{"key":"81962_CR32","first-page":"296","volume":"15","author":"MR Javan","year":"2016","unstructured":"Javan, M. R. et al. Downregulation of immunosuppressive molecules, PD-1 and PD-L1 but not PD-L2, in the patients with multiple sclerosis. Iran J. Allergy Asthma Immunol. 15, 296\u2013302 (2016).","journal-title":"Iran J. Allergy Asthma Immunol."},{"key":"81962_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jhep.2006.05.007","volume":"45","author":"M Muhlbauer","year":"2006","unstructured":"Muhlbauer, M. et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J. Hepatol. 45, 520\u2013528 (2006).","journal-title":"J. Hepatol."},{"key":"81962_CR34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/IGC.0000000000000875","volume":"27","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. Posttranscriptional control of PD-L1 expression by 17beta-estradiol via PI3K\/Akt signaling pathway in eralpha-positive cancer cell lines. Int. J. Gynecol. Cancer. 27, 196\u2013205 (2017).","journal-title":"Int. J. Gynecol. Cancer."},{"key":"81962_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ni0901-777","volume":"2","author":"CC Whitacre","year":"2001","unstructured":"Whitacre, C. C. Sex differences in autoimmune disease. Nat. Immunol. 2, 777\u2013780 (2001).","journal-title":"Nat. Immunol."},{"key":"81962_CR36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0002-9378(16)32998-2","volume":"135","author":"WC Plauche","year":"1979","unstructured":"Plauche, W. C. Myasthenia gravis in pregnancy: an update. Am J Obstet Gynecol. 135, 691\u2013697 (1979).","journal-title":"Am J Obstet Gynecol."},{"key":"81962_CR37","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.4049\/jimmunol.175.8.5050","volume":"175","author":"L Delpy","year":"2005","unstructured":"Delpy, L. et al. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol. 175, 5050\u20135057 (2005).","journal-title":"J. Immunol."},{"key":"81962_CR38","doi-asserted-by":"publisher","first-page":"D98","DOI":"10.1093\/nar\/gkn714","volume":"37","author":"Q Jiang","year":"2009","unstructured":"Jiang, Q. et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucl. Acids Res. 37, D98-104 (2009).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR39","doi-asserted-by":"publisher","first-page":"D902","DOI":"10.1093\/nar\/gkw1038","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. NSDNA: a manually curated database of experimentally supported ncRNAs associated with nervous system diseases. Nucl. Acids Res. 45, D902-d907 (2017).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR40","doi-asserted-by":"publisher","first-page":"D1013","DOI":"10.1093\/nar\/gky1010","volume":"47","author":"Z Huang","year":"2019","unstructured":"Huang, Z. et al. HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucl. Acids Res. 47, D1013\u2013D1017 (2019).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR41","doi-asserted-by":"publisher","first-page":"D43","DOI":"10.1093\/nar\/gkw965","volume":"45","author":"KR Zhou","year":"2017","unstructured":"Zhou, K. R. et al. ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucl. Acids Res. 45, D43\u2013D50 (2017).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR42","doi-asserted-by":"publisher","first-page":"D137","DOI":"10.1093\/nar\/gkl1041","volume":"35","author":"C Jiang","year":"2007","unstructured":"Jiang, C., Xuan, Z., Zhao, F. & Zhang, M. Q. TRED: a transcriptional regulatory element database, new entries and other development. Nucl. Acids Res. 35, D137-140 (2007).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR43","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han, H. et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucl. Acids Res. 46, D380\u2013D386 (2018).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR44","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"CH Chou","year":"2018","unstructured":"Chou, C. H. et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucl. Acids Res. 46, D296-d302 (2018).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR45","doi-asserted-by":"publisher","first-page":"D253","DOI":"10.1093\/nar\/gky1023","volume":"47","author":"Z Tong","year":"2019","unstructured":"Tong, Z., Cui, Q., Wang, J. & Zhou, Y. TransmiR v2.0: an updated transcription factor-microRNA regulation database. Nucl. Acids Res. 47, D253\u2013D258 (2019).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR46","doi-asserted-by":"publisher","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TS Keshava Prasad","year":"2009","unstructured":"Keshava Prasad, T. S. et al. Human protein reference database\u20142009 update. Nucl. Acids Res. 37, D767\u2013D772 (2009).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR47","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/nar\/gkq832","volume":"39","author":"J Xu","year":"2011","unstructured":"Xu, J. et al. MiRNA-miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features. Nucl. Acids Res. 39, 825\u2013836 (2011).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR48","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/17435390.2018.1513090","volume":"12","author":"M Farahani","year":"2018","unstructured":"Farahani, M. et al. Deciphering the transcription factor-microRNA-target gene regulatory network associated with graphene oxide cytotoxicity. Nanotoxicology 12, 1014\u20131026 (2018).","journal-title":"Nanotoxicology"},{"key":"81962_CR49","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucl. Acids Res. 41, D991-995 (2013).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. KEGG: kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 27, 29\u201334 (1999).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR51","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis, G. Jr. et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4, P3 (2003).","journal-title":"Genome Biol."},{"key":"81962_CR52","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucl. Acids Res. 46, D1074-d1082 (2018).","journal-title":"Nucl. Acids Res."},{"key":"81962_CR53","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/09513590600927017","volume":"22","author":"JW Schmidt","year":"2006","unstructured":"Schmidt, J. W., Wollner, D., Curcio, J., Riedlinger, J. & Kim, L. S. Hormone replacement therapy in menopausal women: past problems and future possibilities. Gynecol. Endocrinol. 22, 564\u2013577 (2006).","journal-title":"Gynecol. Endocrinol."},{"key":"81962_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000097485","volume":"84","author":"LM Garcia-Segura","year":"2006","unstructured":"Garcia-Segura, L. M., Sanz, A. & Mendez, P. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 84, 275\u2013279 (2006).","journal-title":"Neuroendocrinology"},{"key":"81962_CR55","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1073\/pnas.76.7.3149","volume":"76","author":"B Forsgren","year":"1979","unstructured":"Forsgren, B. et al. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta. Proc. Natl. Acad. Sci. USA 76, 3149\u20133153 (1979).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"81962_CR56","first-page":"28","volume":"26","author":"DP Petrylak","year":"1999","unstructured":"Petrylak, D. P. et al. Phase I\/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer. Semin. Oncol. 26, 28\u201333 (1999).","journal-title":"Semin. Oncol."},{"key":"81962_CR57","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","volume":"281","author":"SR Cummings","year":"1999","unstructured":"Cummings, S. R. et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. Jama 281, 2189\u20132197 (1999).","journal-title":"Jama"},{"key":"81962_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11914-010-0025-0","volume":"8","author":"SL Silverman","year":"2010","unstructured":"Silverman, S. L. New selective estrogen receptor modulators (SERMs) in development. Curr. Osteoporos Rep. 8, 151\u2013153 (2010).","journal-title":"Curr. Osteoporos Rep."},{"key":"81962_CR59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/00003495-200060020-00013","volume":"60","author":"D Clemett","year":"2000","unstructured":"Clemett, D. & Spencer, C. M. Raloxifene: a review of its use in postmenopausal osteoporosis. Drugs 60, 379\u2013411 (2000).","journal-title":"Drugs"},{"issue":"Suppl 1","key":"81962_CR60","doi-asserted-by":"publisher","first-page":"S269","DOI":"10.1038\/sj.bjp.0706399","volume":"147","author":"VC Jordan","year":"2006","unstructured":"Jordan, V. C. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br. J. Pharmacol. 147(Suppl 1), S269-276 (2006).","journal-title":"Br. J. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81962-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81962-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81962-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:49:42Z","timestamp":1670035782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81962-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["81962"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-81962-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2416"}}